華研精機(301138.SZ):華研製藥主要從事視覺檢測設備業務,目前處於市場開拓階段
格隆匯6月20日丨有投資者向華研精機(301138.SZ)提問:簡單介紹一下子公司勛宇公司、華研製藥公司的情況。
華研精機回覆:三家勛宇子公司(福建勛宇包裝製品有限公司、唐山市勛宇包裝製品有限公司、惠州市勛宇包裝製品有限公司)主要從事PET瓶坯製品的加工、生產與銷售,為客户的工廠提供加工配套服務;華研製藥主要從事視覺檢測設備業務,目前處於市場開拓階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.